Is CyberArk Stock a Buy, Sell or Hold?
CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…
Sell
40
MKL Quote, Financials, Valuation and Earnings
Last price:
$1,834.64
Seasonality move
:
3.16%
Day range:
$1,827.20 - $1,849.53
52-week range:
$1,417.65 - $2,063.68
Dividend yield:
0%
P/E ratio:
9.23x
P/S ratio:
1.43x
P/B ratio:
1.44x
Volume:
54.2K
Avg. volume:
63.6K
1-year change:
20.62%
Market cap:
$23.5B
Revenue:
$16.8B
EPS (TTM):
$199.04
Markel Group Number of Institutional Trades
Markel Group Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$6.5B
(Last 6 Months)
Current Institutional Ownership Percentage
--
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$19.4B
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Markel Group Institutional Ownership
-
What Percentage Of MKL Is Owned by Institutions?
-- of MKL is owned by institutions.
-
How Many Institutions Own MKL Shares?
Markel Group stock is owned by 1,470 institutional shareholders at this time.
-
Have Institutions Been Buying MKL Stock?
Yes, institutions have bought 2.7M shares of MKL in the last quarter.
-
Have Institutions Been Selling MKL Stock?
Yes, institutions have sold 6.5M shares of MKL over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Amazon Stock Still Worth Staking On?
Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…
Is Palantir a Good Stock to Buy?
Palantir Technologies (PLTR) stock soared to its highest level in…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
